EcoDrugPlus

Ensembl ID : ENSCHYG00000020224
Gene Symbol: -
Cross references: -
242 Possible Orthologues:

Ensembl ID : ENSCHYG00000020076
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSCHYG00000019739
Gene Symbol: -
Cross references: -
379 Possible Orthologues:

Ensembl ID : ENSCHYG00000019737
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSCHYG00000019209
Gene Symbol: -
Cross references: -
339 Possible Orthologues:

Ensembl ID : ENSCHYG00000018962
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSCHYG00000018267
Gene Symbol: -
Cross references: -
261 Possible Orthologues:

Ensembl ID : ENSCHYG00000003881
Gene Symbol: -
Cross references: -
159 Possible Orthologues:

Ensembl ID : ENSCHYG00000004005
Gene Symbol: -
Cross references: -
102 Possible Orthologues:

Ensembl ID : ENSCHYG00000004012
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSCHYG00000007859
Gene Symbol: -
Cross references: -
224 Possible Orthologues:

Ensembl ID : ENSCHYG00000018030
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).